Literature DB >> 25046825

Treatment with ginseng total saponins improves the neurorestoration of rat after traumatic brain injury.

Bao-Ying Hu1, Xian-Jin Liu2, Ren Qiang3, Zheng-Lin Jiang4, Li-Hua Xu1, Guo-Hua Wang1, Xia Li1, Bin Peng1.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Ginseng, the root of Panax ginseng C.A. Meyer, is a traditional medicinal herb that has been widely used in Asia for the treatment of many diseases through its effects of reinforcing vitality, strengthening the bodily resistance to pathogenic factors, engendering body liquids and allaying thirst, relieving uneasiness of the body and mind and benefiting intelligence, reducing body weight and prolonging life. Ginsenosides are the most important biologically active substances in ginseng. Many reports have suggested that ginsenosides could exert prominent neuroprotective and neurotrophic effects, promote neural stem/progenitor cell (NSC) proliferation and promote neurite outgrowth and neuronal network formation. The present study aimed to investigate whether treatment with ginsenosides could facilitate NSC proliferation in the hippocampal formation after traumatic brain injury (TBI) and contribute to the recovery of neurological functions including learning and memory.
MATERIALS AND METHODS: The modified Feeney׳s method was used to induce a TBI in rats. Ginseng total saponins (GTS) were treated intraperitoneally twice a day for 1 week after the TBI. The neurological functions, morphology of the hippocampus, expression of nerve growth-related factors and number of NSCs in the hippocampal formation ipsilateral to the trauma were determined.
RESULTS: We determined 1) GTS (5-80 mg/kg) treatment after a TBI improved the recovery of neurological functions, including learning and memory, and reduced cell loss in the hippocampal area. The effects of GTS at 20, 40, 60, and 80 mg/kg were better than the effects of GTS at 5 and 10 mg/kg. 2) GTS treatment (20 mg/kg) after a TBI increased the expression of NGF, GDNF and NCAM, inhibited the expression of Nogo-A, Nogo-B, TN-C, and increased the number of BrdU/nestin positive NSCs in the hippocampal formation.
CONCLUSIONS: GTS treatment in rats after a TBI alleviated the secondary brain injury and ameliorated the neurological functions with an effective dose limit of 5-80 mg/kg. GTS regulated the expression of nerve growth-related factors and improved the proliferation of neural stem/progenitor cells, which might facilitate neural regeneration and tissue repair, and might contribute to the recovery of neurological functions, including learning and memory. These effects of GTS might provide a foundation for the use of ginseng as a medicinal herb to enhance intelligence, reduce the aging process and prolong life in the traditional medicine.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ginseng total saponins; Neural stem/progenitor cell; Neuroprotection; Neurorestoration; Rat; Traumatic brain injury

Mesh:

Substances:

Year:  2014        PMID: 25046825     DOI: 10.1016/j.jep.2014.07.009

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Therapeutic effects of astragaloside IV and Astragalus spinosus saponins against bisphenol A-induced neurotoxicity and DNA damage in rats.

Authors:  Amina E Essawy; Heba-Tallah Abd Elrahim Abd Elkader; Omaima A Khamiss; Saber Mohamed Eweda; Heba Mohamed Abdou
Journal:  PeerJ       Date:  2021-08-09       Impact factor: 2.984

Review 3.  The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer's disease: a systematic review.

Authors:  Chenxia Sheng; Weijun Peng; Zi-An Xia; Yang Wang; Zeqi Chen; Nanxiang Su; Zhe Wang
Journal:  BMC Complement Altern Med       Date:  2015-10-24       Impact factor: 3.659

4.  The Expression of NP847 and Sox2 after TBI and Its Influence on NSCs.

Authors:  Jun Gu; Yifeng Bao; Jian Chen; Chuanjun Huang; Xinghua Zhang; Rui Jiang; Qianqian Liu; Yonghua Liu; Xide Xu; Wei Shi
Journal:  Front Cell Neurosci       Date:  2016-12-22       Impact factor: 5.505

5.  Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease.

Authors:  Hai-Yong Liang; Pei-Pei Zhang; Xi-Le Zhang; Yan-Yan Zheng; Yan-Ran Huang; Guo-Qing Zheng; Yan Lin
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

6.  Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampal Neuronal Apoptosis in Experimental Vascular Dementia Mice by Promoting GPR30 Expression.

Authors:  Fengming Shen; Juan Wang; Feng Gao; Jingji Wang; Guoqi Zhu
Journal:  Neural Plast       Date:  2021-12-03       Impact factor: 3.599

Review 7.  Protective Effects and Network Analysis of Ginsenoside Rb1 Against Cerebral Ischemia Injury: A Pharmacological Review.

Authors:  Weijie Xie; Xinyue Wang; Tianbao Xiao; Yibo Cao; Yumei Wu; Dongsheng Yang; Song Zhang
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

8.  Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway.

Authors:  Sibin Guan; Weiguo Xu; Fengfeng Han; Wen Gu; Lin Song; Wenjing Ye; Qian Liu; Xuejun Guo
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

Review 9.  Hormesis and Ginseng: Ginseng Mixtures and Individual Constituents Commonly Display Hormesis Dose Responses, Especially for Neuroprotective Effects.

Authors:  Edward J Calabrese
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

10.  HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways.

Authors:  Weijie Xie; Ting Zhu; Xi Dong; Fengwei Nan; Xiangbao Meng; Ping Zhou; Guibo Sun; Xiaobo Sun
Journal:  Biomolecules       Date:  2019-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.